BACKGROUND: Structural heart disease, including valvular disease as well as congenital defects, causes important alterations in heart anatomy. As a result, individualised planning for both surgical and percutaneous procedures is crucial for procedural optimisation. Three dimensional (3D) rapid prototyping techniques are being utilised to aid operators in planning structural heart procedures. AIM: We intend to provide a description of 3D printing as a clinically applicable heart modelling technology for the planning of percutaneous structural heart procedures as well as to report our first clinical use of a 3D printed patient-specific heart model in preparation for a percutaneous mitral annuloplasty using the Mitralign percutaneous annuloplasty system. METHODS: Retrospectively gated, contrast enhanced, multi-slice computed tomography (MSCT) scans were obtained. MSCT DICOM data was analysed using software that creates 3D surface files of the blood volume of specific regions of interest in the heart. The surface files are rendered using a software package that creates a solid model that can be printed using commercially available stereolithography machines. RESULTS: The technique of direct percutaneous mitral annuloplasty requires advancement of a guiding catheter through the aorta, into the left ventricle, and requires the positioning of the tip of the catheter between the papillary muscles in close proximity to the mitral annulus. The 3D heart model was used to create a procedural plan to optimise potential device implantation. The size of the deflectable guiding catheter was selected on the basis of the patient's heart model. Target locations for annulus crossing wires were evaluated pre-procedurally using the individual patient's 3D heart model. In addition, the ability to position the Bident Catheter at the appropriate locations under the mitral annulus as well as the manoeuvrability between the papillary muscles were analysed on the heart model, enabling safe completion of the procedure, which resulted in a significant reduction in mitral regurgitation. CONCLUSIONS: 3D printing is a helpful tool in individualised planning for percutaneous structural interventions. Future studies are warranted to assess its role in preparing for percutaneous and surgical heart procedures.
BACKGROUND:Structural heart disease, including valvular disease as well as congenital defects, causes important alterations in heart anatomy. As a result, individualised planning for both surgical and percutaneous procedures is crucial for procedural optimisation. Three dimensional (3D) rapid prototyping techniques are being utilised to aid operators in planning structural heart procedures. AIM: We intend to provide a description of 3D printing as a clinically applicable heart modelling technology for the planning of percutaneous structural heart procedures as well as to report our first clinical use of a 3D printed patient-specific heart model in preparation for a percutaneous mitral annuloplasty using the Mitralign percutaneous annuloplasty system. METHODS: Retrospectively gated, contrast enhanced, multi-slice computed tomography (MSCT) scans were obtained. MSCT DICOM data was analysed using software that creates 3D surface files of the blood volume of specific regions of interest in the heart. The surface files are rendered using a software package that creates a solid model that can be printed using commercially available stereolithography machines. RESULTS: The technique of direct percutaneous mitral annuloplasty requires advancement of a guiding catheter through the aorta, into the left ventricle, and requires the positioning of the tip of the catheter between the papillary muscles in close proximity to the mitral annulus. The 3D heart model was used to create a procedural plan to optimise potential device implantation. The size of the deflectable guiding catheter was selected on the basis of the patient's heart model. Target locations for annulus crossing wires were evaluated pre-procedurally using the individual patient's 3D heart model. In addition, the ability to position the Bident Catheter at the appropriate locations under the mitral annulus as well as the manoeuvrability between the papillary muscles were analysed on the heart model, enabling safe completion of the procedure, which resulted in a significant reduction in mitral regurgitation. CONCLUSIONS: 3D printing is a helpful tool in individualised planning for percutaneous structural interventions. Future studies are warranted to assess its role in preparing for percutaneous and surgical heart procedures.
Authors: Animesh Tandon; Nicholas Byrne; Maria de Las Nieves Velasco Forte; Song Zhang; Adrian K Dyer; Jeanne M Dillenbeck; Gerald F Greil; Tarique Hussain Journal: Int J Cardiovasc Imaging Date: 2016-05-12 Impact factor: 2.357
Authors: Puneet Bhatla; Justin T Tretter; Achi Ludomirsky; Michael Argilla; Larry A Latson; Sujata Chakravarti; Piers C Barker; Shi-Joon Yoo; Doff B McElhinney; Nicole Wake; Ralph S Mosca Journal: Pediatr Cardiol Date: 2016-11-11 Impact factor: 1.655
Authors: Andreas A Giannopoulos; Dimitris Mitsouras; Shi-Joon Yoo; Peter P Liu; Yiannis S Chatzizisis; Frank J Rybicki Journal: Nat Rev Cardiol Date: 2016-10-27 Impact factor: 32.419
Authors: Beth Ripley; Tatiana Kelil; Michael K Cheezum; Alexandra Goncalves; Marcelo F Di Carli; Frank J Rybicki; Mike Steigner; Dimitrios Mitsouras; Ron Blankstein Journal: J Cardiovasc Comput Tomogr Date: 2015-12-12
Authors: Ramtin Gharleghi; Claire A Dessalles; Ronil Lal; Sinead McCraith; Kiran Sarathy; Nigel Jepson; James Otton; Abdul I Barakat; Susann Beier Journal: Ann Biomed Eng Date: 2021-05-17 Impact factor: 3.934